Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Marc P Bonaca Added: 5 months ago
AHA Conference 2024 - New insights from the CLEAR OUTCOMES trial investigating bempedoic acid (Esperion Therapeutics Inc.) in statin-intolerant patients with peripheral arterial disease (PAD).Dr Marc Bonaca (University of Colorado School of Medicine, Colorado, US) joins us onsite at AHA Conference to discuss new insights from CLEAR OUTCOMES (NCT02993406).CLEAR OUTCOMES is a double-blind,… View more
Job title: Director
Job title: Associate Professor – Department of Health Research Methods, Evidence, and Impact (HEI)
Dr Andrew Mente is a Principal Investigator for the Epidemiology program at the Population Health Research Institute and Associate Professor – Department of Health Research Methods, Evidence, and Impact (HEI), McMaster University. Dr Mente received his doctoral degree in Epidemiology from the University of Toronto and completed post-doctoral training in cardiovascular epidemiology at McMaster… View more
Author(s): Samuel S Engel Added: 1 year ago
EASD 2023 — In this short interview, Dr Samuel S Engel (Associate Vice President at Merck) discusses a study investigating the effectiveness and safety of efinopegdutide (MK-6024) in patients with nonalcoholic fatty liver disease and type 2 diabetes (NCT04944992).The phase IIa study randomized 145 participants (efinopegdutide, n = 72; semaglutide, n = 73). The majority (55.2%) of participants… View more